->->-> Pilot & Seed Grants | Funding Opportunities | Resources for Investigators & Trainees | Research | Perelman School of Medicine University of Pennsylvania

Pilot & Seed Grants


Many of the PSOM's centers and institutes sponsor pilot and seed grant programs. Each of these programs has different deadlines and these vary from year to year. Contact the individuals listed below for current information:



Cardiovascular Institute (CVI)

Periodically, generally in preparation for multi-disciplinary awards (PO-1's, SCCORs, Roadmap initiatives), the Penn CVI leadership will issue Request for Proposals (RFPs) in order to generate strategically targeted preliminary studies required prior to, or in preparation for, an institutional application or award.

Any Penn faculty member working in the strategically-targeted area, or a closely related area, is encouraged to apply for this funding. These funds are not restricted to investigators with a track record of cardiovascular investigation. Applications from research scientists who have not historically focused their studies in cardiovascular science are encouraged to apply for funding.

The amount of available funding will vary depending upon the RFP, but generally range from $25,000 per year to $200,000 per year. The application process has been streamlined to encourage faculty members to apply for funding.

For more information, please visit the Penn CVI Business Office.


Center for Healthcare Improvement and Patient Safety (CHIPS)

CHIPS supports comparative effectiveness research and research designed to reduce human and system errors and thereby improve the outcomes for patients in hospital and ambulatory care settings.

In an effort to stimulate quality improvement and patient safety research within the Penn community, the Center offers grants of up to $10,000 to new investigators to conduct pilot studies in preparation for larger research projects. The awards provide new investigators with funds to obtain preliminary data regarding feasibility and methodology, effect sizes and findings relating to new research ideas relevant to healthcare quality, safety, efficiency, and effectiveness. Eligible pilot projects should be designed to collect sufficient preliminary data to enable the investigator to prepare a hypothesis-based proposal for future research funding.

To apply for pilot grant funding, please complete the CHIPS pilot grant application form and return it via email to crosset2@mail.med.upenn.edu.


Diabetes Research Center (DRC)

Pilot and Feasibility Grants
Application Deadline:  December 1, 2014

The Diabetes Research Center (DRC) of the University of Pennsylvania is now accepting applications for support to perform pilot and feasibility studies in diabetes and related endocrine and metabolic disorders.

The P&F program is particularly directed at new investigators and established investigators new to diabetes research. Established diabetes investigators pursuing high impact/high risk projects or projects that are a significant departure from their usual work are also eligible for support under the DRC P&F program. Applications are welcome from basic, clinical and translational investigators. In addition, up to two applications will be awarded for funding of metabolomics projects to be conducted by the DRC Regional Metabolomics Core at Princeton University.

Grants will be reviewed by the DRC Pilot and Feasibility Review Committee as well as internal and external reviewers.  Funding level maximum is $50,000. For the Metabolomics Pilot awards, funding level maximum is $16,000 per award, to be spent directly at the Princeton Core.  Current Award period: April 1, 2015-March 31, 2016.

For detailed information including application instructions visit: http://www.med.upenn.edu/idom/derc/pilots.html

If human or animal subjects will be participating in the proposed research, IRB or IACUC approval will be required. Approval may be pending at the time of application but funds will not be disbursed without copies of the approval letters. Equipment, travel funds and investigator salary are not permitted on this award.

Investigators who are currently in the first year of support through this P&F Program may reapply for an additional year of funding.  Such continuation requests need to be carefully justified, however, and will be considered as competing renewals. 

Application Deadline: Monday, December 1, 2014.  For information, please contact Vesselina Panteva via telephone:  (215) 898-0198 or email: panteva@mail.med.upenn.edu or Dr. Doris Stoffers, director, DRC Pilot & Feasibility Grants Program via telephone:  (215) 573-5413 or email: stoffers@mail.med.upenn.edu

 

- See more at: http://www.upenn.edu/almanac/volumes/v61/n08/drc-grants.html#sthash.qXimWpFi.dpuf

The Diabetes Research Center (DRC) of the University of Pennsylvania is now accepting applications for support to perform pilot and feasibility studies in diabetes and related endocrine and metabolic disorders.

The P&F program is particularly directed at new investigators and established investigators new to diabetes research. Established diabetes investigators pursuing high impact/high risk projects or projects that are a significant departure from their usual work are also eligible for support under the DRC P&F program. Applications are welcome from basic, clinical and translational investigators. In addition, up to two applications will be awarded for funding of metabolomics projects to be conducted by the DRC Regional Metabolomics Core at Princeton University.

Grants will be reviewed by the DRC Pilot and Feasibility Review Committee as well as internal and external reviewers.  Funding level maximum is $50,000. For the Metabolomics Pilot awards, funding level maximum is $16,000 per award, to be spent directly at the Princeton Core.  Current Award period: April 1, 2015-March 31, 2016.

For detailed information including application instructions visit: http://www.med.upenn.edu/idom/derc/pilots.html

If human or animal subjects will be participating in the proposed research, IRB or IACUC approval will be required. Approval may be pending at the time of application but funds will not be disbursed without copies of the approval letters. Equipment, travel funds and investigator salary are not permitted on this award.

Investigators who are currently in the first year of support through this P&F Program may reapply for an additional year of funding.  Such continuation requests need to be carefully justified, however, and will be considered as competing renewals. 

Application Deadline: Monday, December 1, 2014.  For information, please contact Vesselina Panteva via telephone:  (215) 898-0198 or email: panteva@mail.med.upenn.edu or Dr. Doris Stoffers, director, DRC Pilot & Feasibility Grants Program via telephone:  (215) 573-5413 or email: stoffers@mail.med.upenn.edu

- See more at: http://www.upenn.edu/almanac/volumes/v61/n08/drc-grants.html#sthash.qXimWpFi.dpuf

The Diabetes Research Center (DRC) of the University of Pennsylvania is now accepting applications for support to perform pilot and feasibility studies in diabetes and related endocrine and metabolic disorders.

The P&F program is particularly directed at new investigators and established investigators new to diabetes research. Established diabetes investigators pursuing high impact/high risk projects or projects that are a significant departure from their usual work are also eligible for support under the DRC P&F program. Applications are welcome from basic, clinical and translational investigators. In addition, up to two applications will be awarded for funding of metabolomics projects to be conducted by the DRC Regional Metabolomics Core at Princeton University.

Grants will be reviewed by the DRC Pilot and Feasibility Review Committee as well as internal and external reviewers.  Funding level maximum is $50,000. For the Metabolomics Pilot awards, funding level maximum is $16,000 per award, to be spent directly at the Princeton Core.  Current Award period: April 1, 2015-March 31, 2016.

For detailed information including application instructions visit: http://www.med.upenn.edu/idom/derc/pilots.html

If human or animal subjects will be participating in the proposed research, IRB or IACUC approval will be required. Approval may be pending at the time of application but funds will not be disbursed without copies of the approval letters. Equipment, travel funds and investigator salary are not permitted on this award.

Investigators who are currently in the first year of support through this P&F Program may reapply for an additional year of funding.  Such continuation requests need to be carefully justified, however, and will be considered as competing renewals. 

Application Deadline: Monday, December 1, 2014.  For information, please contact Vesselina Panteva via telephone:  (215) 898-0198 or email: panteva@mail.med.upenn.edu or Dr. Doris Stoffers, director, DRC Pilot & Feasibility Grants Program via telephone:  (215) 573-5413 or email: stoffers@mail.med.upenn.edu

- See more at: http://www.upenn.edu/almanac/volumes/v61/n08/drc-grants.html#sthash.qXimWpFi.dpuf

The Diabetes Research Center (DRC) of the University of Pennsylvania is now accepting applications for support to perform pilot and feasibility studies in diabetes and related endocrine and metabolic disorders.

The P&F program is particularly directed at new investigators and established investigators new to diabetes research. Established diabetes investigators pursuing high impact/high risk projects or projects that are a significant departure from their usual work are also eligible for support under the DRC P&F program. Applications are welcome from basic, clinical and translational investigators. In addition, up to two applications will be awarded for funding of metabolomics projects to be conducted by the DRC Regional Metabolomics Core at Princeton University.

Grants will be reviewed by the DRC Pilot and Feasibility Review Committee as well as internal and external reviewers.  Funding level maximum is $50,000. For the Metabolomics Pilot awards, funding level maximum is $16,000 per award, to be spent directly at the Princeton Core.  Current Award period: April 1, 2015-March 31, 2016.

For detailed information including application instructions visit: http://www.med.upenn.edu/idom/derc/pilots.html

If human or animal subjects will be participating in the proposed research, IRB or IACUC approval will be required. Approval may be pending at the time of application but funds will not be disbursed without copies of the approval letters. Equipment, travel funds and investigator salary are not permitted on this award.

Investigators who are currently in the first year of support through this P&F Program may reapply for an additional year of funding.  Such continuation requests need to be carefully justified, however, and will be considered as competing renewals. 

Application Deadline: Monday, December 1, 2014.  For information, please contact Vesselina Panteva via telephone:  (215) 898-0198 or email: panteva@mail.med.upenn.edu or Dr. Doris Stoffers, director, DRC Pilot & Feasibility Grants Program via telephone:  (215) 573-5413 or email: stoffers@mail.med.upenn.edu


Institute for Translational Medicine and Therapeutics (ITMAT)

TAPITMAT Transdisciplinary Awards Program in Translational Medicine and Therapeutics

Application due date: Friday, December 5, 2014, at noon.

The Institute for Translational Medicine and Therapeutics (ITMAT) invites proposals from ITMAT Members and ITMAT Associate Members in the Research Associate or Instructor A category. It is not too late to become a Member or an Associate Member if you would like to apply for the grant and meet membership criterion. If you are interested, please visit the membership section of our website for details.

The proposals must center on the translational space - in terms of drug development, from proof of concept in cells or model systems through to mechanistic studies in humans or, in drug development, completion of dose selection in Phase II. Programs that plan to progress within that space and which deploy technologies and approaches conventionally segregated from each other within the traditionally boundaries of academic medicine will be especially favored.

The proposals are due by December 5, 2014, for a proposal start date of February 1, 2015.

TAPITMAT TBIC Translational Biomedical Imaging Center
Application due date: Friday, December 5, 2014, at noon.

The Translational Biomedical Imaging Center (TBIC) was established under the leadership of the ITMAT in part "to broaden and accelerate translational imaging research through the development of a center to bring together investigators with diverse backgrounds that contribute to various aspects of imaging science and who share a vision of contributing to the advancement of clinical medicine." Among the approaches adopted by the TBIC to promote the use of imaging technology to facilitate translational research are the support of core facilities, collaborative imaging scientists, and retreats/seminars. Building on this foundation, the TBIC announces a new collaborative pilot grant program to help catalyze collaborations between primary imaging scientists and primary biomedical/clinical researchers that integrate novel imaging approaches to enhance translational science and medicine.

These proposals require at least two Co-Principal Investigators, one investigator whose primary research focus is in imaging methodology development and another investigator whose research is focused on biomedical science. At least one of the co-principal investigators should have a primary appointment in the School of Medicine. The TBIC adopts a broad definition of imaging science and seeks proposals that focus on anatomic or functional imaging approaches that span from the microscopic to in vivo regimes. Proposals that include a broad range of imaging methods including image acquisition techniques, image analysis, imaging probe development will be considered. Funding will be based on scientific merit, potential downstream clinical impact and the likelihood that the project will generate independent funding to sustain the effort. Post-pilot award outcomes will be surveyed. The deadline for applications is December 5, 2014, for an award start date of February 1, 2015.

For additional information, please visit our website or contact Drs. Mitchell Schnall at mitchell.schnall@uphs.upenn.edu or James Gee at gee@mail.med.upenn.edu.

TAPTIMAT CT³N Center for Targeted Therapeutics and Translational Nanomedicine
Application due date: Friday, December 5, 2014, at noon.

The CT³N invites PENN and CHOP researchers to submit competitive proposals for Pilot Grants by December 5, 2014. The goal of these Pilot Grants is to support early-stage experimental preclinical studies in targeted therapeutics and thus assist investigators in obtaining key data to seek extramural funding. The grants will be for up to $25,000 for one year, starting February 1, 2015.


Penn Center for Musculoskeletal Disorder

PCMD Funds Available

We would like to introduce you to a new funding mechanism within our Penn Center for Musculoskeletal Disorders. In short, if you have a recent summary statement from an NIH grant (eligible NIH mechanisms include all "R" grants such as R03, R21 and R01 and "P" grants such as P20, P50, P60 on their first submission – please inquire regarding eligibility of other proposal mechanisms) which requires you to run additional experiments, gather additional data, provide feasibility for an approach, or similar, we can provide small funds ($1,000–$15,000) with a very short turn-around time in order to allow you to complete these experiments and resubmit your proposal with the best chance of success. Requests for funding will be evaluated on a rolling basis and priority will be given to Assistant Professors with encouraging initial review priority scores better than ~30-35%. The format of the "Summary Statement Driven Funding Request", which is limited to one page, is as follows.

  • Name of PI (must be a PCMD member)
  • Title of Project Request
  • Specific Purpose of Request with Stated Outcome/Goal Referring Explicitly to the Summary Statement for Justification
  • Research Design and Methods
  • Budget with Brief Justification

In addition to the one page proposal, the PDF of the complete summary statement must be provided. Funding through this mechanism is available by submitting the one page proposal and summary statement to pcmd@mail.med.upenn.edu.

If you have any questions or comments, please contact us:

pcmd@mail.med.upenn.edu


Penn Genome Frontiers Institute (PGFI)

The Penn Genome Frontiers Institute provides support to PENN researchers in several ways, including providing funding opportunities for faculty and graduate students.

PGFI has funded research in strategic areas of the genome sciences. These pilot grants provide the means to pursue innovative, and often risky, ideas to the point that the investigators are able to apply for conventional funding mechanisms. Typically grants are awarded for one to two years, for up to $120,000.

For more information, please visit the PGFI website.


Robert Wood Johnson Health & Society Scholars Pilot Program

The Robert Wood Johnson Foundation Health & Society Scholars Program at the University of Pennsylvania (RWJF H&SSP at Penn) has set aside a Competitive Research and Education Fund to promote interdisciplinary research and education in population health at Penn. These funds will be used to help Penn faculty develop pilot projects which will attract external support for larger-scale studies, as well as new and innovative didactic material.

Please visit www.upenn.edu/rwjhssp for more information and further details.

For additional information please contact:

Melissa Kulynych
Program Coordinator
215-746-7744
215-746-0397
mkulynyc@wharton.upenn.edu